October 28th 2024
The CEO discusses the current state of compounding pharmacies and how it built to this point.
September 16th 2024
Navigating the Increasing Complexity of Drug-Biomarker Co-Development
September 10th 2018To succeed in developing targeted medicines, companies need a biomarker strategy and the expertise to make smart decisions about clinical trial design, assays, technology platforms and collaborative partners, write Barry S. Sall and Angela X. Qu.
Navigating the Complex Reimbursement and Policy Landscape of Healthcare Access
August 13th 2018Tommy Bramley and Kristine Flemister discuss today’s increasingly complex healthcare environment, and share insights into how stakeholders should be evolving to better help patients and providers navigate barriers around access and affordability.
Piecing Together the Pricing Puzzle: The Midterm Elections
June 10th 2018There is no magic bullet that will dramatically impact drug pricing to everybody’s liking. But a stepwise approach involving a series of reforms, including taking advantage of the next midterm elections, could point the path toward a solution.
Patient Adherence and Human Nature
April 15th 2018With less than 50% of patients with long-term conditions remaining adherent to their recommended treatment, we need to look to behavioral science to deconstruct the barriers that make people act in ways that can seem self-defeating, writes Jim O'Donaghue.